ArticleClinical rheumatology2026

Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Daniela Iacono et al.PubMed ↗Publisher ↗

No numbers read from the abstract.